Tue, August 15, 2023

Joon Lee Maintained (TSHA) at Strong Buy with Increased Target to $6 on, Aug 15th, 2023

Joon Lee of Truist Securities, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Increased Target from $2 to $6 on, Aug 15th, 2023.

Joon has made no other calls on TSHA in the last 4 months.



There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Joon's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joon


  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $7 on, Monday, August 14th, 2023
  • Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $13 on, Thursday, July 6th, 2023